How often do you find yourself reading about successful IPOs? In my experience, not very often. Most business media outlets prefer to cover train wrecks. They're sexier. While bad IPOs may get all the press, let's see if we can find a good one.

IN PICTURES: Eight Ways To Survive A Market Downturn

Case in point, Fortress Investment Group (NYSE:FIG), the first global alternative asset manager listed on the New York Stock Exchange. A Fortune magazine article reported that David Swensen, Chief Investment Officer of the Yale Endowment Fund, believes the five principles at Fortress are notoriously greedy, leaving regular investors with table scraps while the partners make out like bandits. This seems like a "bad" IPO and its numbers don't make it seem any better.

Failure To Deliver
In its 2007 prospectus, Fortress brags about a 98.6% compounded annual growth rate in assets under management between December 31, 2001 and September 30, 2006. Since going public in February 2007, this number actually shrank from $29.9 billion in September 2006 to $29.5 billion at the end of 2008. A little more than two years out of the gate and FIG is already in the dumpster.

New investors who bought a piece of the offering clearly are wishing they didn't. Priced at $18.50, it's now trading below $4.

Only Nomura Investment Managers seems to see light at the end of the tunnel. Despite being underwater by about $675 million, it bought another 5.4 million shares in a secondary offering in May for $27 million. That's putting a great deal of faith in five people who already banked $1.66 billion prior to the IPO and still hold $1.3 billion in stock despite a two-year, 75% drop in its stock price.

For those doubting the Fab Five's ability to get the job done, you could always take a look at other overpaid hedge fund companies like Blackstone Group (NYSE:BX) and GLG Partners (NYSE:GLG). They too have failed to deliver.

Good Offers Tough To Find
A good IPO is an offering that balances the needs of existing investors with those of new ones. By doing so, everyone wins. Anything less is irresponsible. Corporate finance, M&A and all other fundraising professionals suffer as a result.

One IPO that does a nice job meeting investors needs is Alnylam Pharmaceuticals (Nasdaq:ALNY), a developer of therapeutic drugs based on RNA interference, which essentially acts as an agent to silence certain genes. Current drugs in development include those for age-related macular degeneration and Parkinson's disease. The company is not yet making money, but it's getting close.

In 2006, sales for Alnylam were $27 million with a $34.6 million loss. Two years later, it generated $96.2 million in sales with a net loss of $26.2 million. With a little luck, it could break through into the profit zone sometime in 2010.

On June 10, both Roth and Jefferies & Co. initiated coverage of the biopharmaceutical newbie with a "buy" rating. Why not? Its stock is up 260% since going public. That's much better than similarly valued pharmaceutical firms Medarex (NYSE:MRX) and Medicis Pharmaceutical (Nasdaq:MEDX).

However, the most impressive finding is that the spread between what new IPO investors paid ($6 per share) and existing ones ($4.48 per share) was only 25%, representing a true partnership. Fortress only wishes it could say the same.

The Bottom Line
Good IPOs are win/win situations like Alnylam Pharmaceuticals. IPOs like Fortress, Blackstone Group and other asset management offerings only benefit the favored few. Staying away from them could mean a more secure financial future. (Read Hedge Funds' Higher Returns Come At A Price for more on this topic.)

Related Articles
  1. Products and Investments

    There's a Reason They're Called Junk Bonds

    The closing of Third Avenue Managemet's Focused Credit Fund is a warning to investors and advisors. Beware the junk.
  2. Stock Analysis

    Tribune Media: An Activist Investment Analysis (TRCO)

    Learn more about the breakup of Tribune Company, once a powerful newspaper and broadcasting giant, and the role of activist investor Cliff Robbins.
  3. Stock Analysis

    Air Products and Chemicals: An Activist Investment Analysis (APD)

    Learn about the productive, and uncommonly friendly, activist investment made by Bill Ackman into Air Products and Chemicals.
  4. Stock Analysis

    Analyzing Altria's Return on Equity (ROE) (MO)

    Learn about Altria Group's return on equity (ROE) and analyze net profit margin, asset turnover and financial leverage to determine what is causing its high ROE.
  5. Investing News

    Icahn's Bet on Cheniere Energy: Should You Follow?

    Investing legend Carl Icahn continues to lose money on Cheniere Energy, but he's increasing his stake. Should you follow his lead?
  6. Stock Analysis

    Analyzing Google's Return on Equity (ROE) (GOOGL)

    Learn about Alphabet's return on equity. How has its ROE changed over time, how does it compare to its peers and what factors are driving ROE for the company?
  7. Investing News

    Is Buffett's Bet on Oil Right for You? (XOM, PSX)

    Oil stocks are getting trounced, but Warren Buffett still likes one of them. Should you follow the leader?
  8. Investing

    3 Things About International Investing and Currency

    As world monetary policy continues to diverge rocking bottom on interest rates while the Fed raises them, expect currencies to continue their bumpy ride.
  9. Stock Analysis

    Jana Partners: An Activist Investor Analysis

    Learn about Jana Partners, a hedge fund founded by Barry Rosenstein. Read about new positions in ConAgra and Qualcomm the fund took in 2015.
  10. Investing News

    Chipotle Served with Criminal Probe

    Chipotle's beat muted expectations and got a clear bill from the CDC, but it now appears that an investigation into its E.coli breakout has expanded.
  1. What is securitization?

    Securitization is the process of taking an illiquid asset, or group of assets, and through financial engineering, transforming ... Read Full Answer >>
  2. Can hedge funds trade penny stocks?

    Hedge funds can trade penny stocks. In fact, hedge funds can trade in just about any type of security, including medium- ... Read Full Answer >>
  3. Are hedge funds regulated by FINRA?

    Alternative investment vehicles such as hedge funds offer investors a wider range of possibilities due to certain exceptions ... Read Full Answer >>
  4. Should mutual funds be subject to more regulation?

    Mutual funds, when compared to other types of pooled investments such as hedge funds, have very strict regulations. In fact, ... Read Full Answer >>
  5. Can hedge fund returns be replicated?

    You can replicate hedge fund returns to a degree but not perfectly. Most replication strategies underperform hedge funds ... Read Full Answer >>
  6. Can foreign investors invest in US hedge funds?

    U.S. hedge funds are open to accredited investors. When they distribute profits to investors, those proceeds are taxed at ... Read Full Answer >>
Trading Center